Skip to content
★ Sign in to follow
RS

Ruedi Stalder

Eloxx Pharmaceuticals, Inc.
Total declarations
12
Company
1
▲ Purchases (8 ops.)
€24k
▼ Sales (0 ops.)
—

Latest filing published 27 May 2010 for Eloxx Pharmaceuticals, Inc., €8,489.

Insider track record

Disclosed buys
8
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
8

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Ruedi Stalder: trading record in brief

Ruedi Stalder is a declared insider of Eloxx Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 11 October 2006 to 25 May 2010, the count stands at 12 filings.

On the market, this insider has only ever bought: 8 purchases, €24k in total. The amount is not disclosed for 3 filings. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 3 share grants. 2010 to date brings 1 purchase and no sales.

A typical purchase (the median) is worth €2,862.

The latest filing, published on 27 May 2010, reports a share grant of €8,489 in Eloxx Pharmaceuticals, Inc. The latest purchase dates back some time: it was published 6,103 days ago, on 23 February 2010. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.

Companies and markets linked to Ruedi Stalder

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations11 total

11 of 11 declarations